Latest filing published 18 Aug 2009 for CardioVascular BioTherapeutics, Inc., €17k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Thomas Stegmann: trading record in brief
All filings by Thomas Stegmann on record concern CardioVascular BioTherapeutics, Inc. We count 128 filings; the first trade dates from 22 March 2006 and the latest from 11 August 2009.
The open-market side counts 7 purchases for €163k alongside 118 sales for €1.8M. Taken together, the sales exceed the purchases by €1.7M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 2 share grants. 2009 to date brings no purchases and 118 sales.
The median purchase comes to €19k.
The record was last updated on 18 August 2009 with an open-market sale (€17k) in CardioVascular BioTherapeutics, Inc. The last insider purchase was made public on 12 December 2006, 7,271 days ago. Filings reach the SEC (Form 4) feed a median of 6 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Thomas Stegmann
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 100,000 shares@ US$0.239Common StockSEC:0001314771-09-000011:0
- 200,000 shares@ US$0.24Common StockSEC:0001314771-09-000011:1
- 200,000 shares@ US$0.25Common StockSEC:0001314771-09-000011:2
- 200,000 shares@ US$0.26Common StockSEC:0001314771-09-000011:3
- 200,000 shares@ US$0.27Common StockSEC:0001314771-09-000011:4
- 200,000 shares@ US$0.28Common StockSEC:0001314771-09-000011:5
- 218,693 shares@ US$0.27Common StockSEC:0001314771-09-000011:6
- 200,000 shares@ US$0.275Common StockSEC:0001314771-09-000011:7
- 107,000 shares@ US$0.155Common StockSEC:0001314771-09-000010:0
- 120,065 shares@ US$0.15Common StockSEC:0001314771-09-000010:1
- 242,335 shares@ US$0.15Common StockSEC:0001314771-09-000010:2
- 400,000 shares@ US$0.15Common StockSEC:0001314771-09-000010:3
- 200,000 shares@ US$0.155Common StockSEC:0001314771-09-000010:4
- 200,000 shares@ US$0.16Common StockSEC:0001314771-09-000010:5
- 200,000 shares@ US$0.16Common StockSEC:0001314771-09-000010:6
- 200,000 shares@ US$0.165Common StockSEC:0001314771-09-000010:7
- 200,000 shares@ US$0.17Common StockSEC:0001314771-09-000010:8
- 400,000 shares@ US$0.175Common StockSEC:0001314771-09-000010:9
- 500,000 shares@ US$0.18Common StockSEC:0001314771-09-000010:10
- 400,000 shares@ US$0.185Common StockSEC:0001314771-09-000010:11
- 200,000 shares@ US$0.19Common StockSEC:0001314771-09-000010:12
- 200,000 shares@ US$0.20Common StockSEC:0001314771-09-000010:13
- 200,000 shares@ US$0.21Common StockSEC:0001314771-09-000010:14
- 200,000 shares@ US$0.22Common StockSEC:0001314771-09-000010:15
- 295,250 shares@ US$0.16Common StockSEC:0001314771-09-000009:0
25 of 122 declarations